SFX by Ex Libris Inc.

Title:	Botulinum neurotoxin C1 blocks neurotransmitter release by means of cleaving HPC-1/syntaxin.
Source:	Embo Journal [0261-4189] Blasi, J yr:1993

Basic

Full text

Full text available via PubMed Central

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Breidenbach, A. "Substrate recognition strategy for botulinum neurotoxin serotype A." Nature 432.7019 (2004): 925-929.
description	2.	Simpson, L L. "Kinetic studies on the interaction between botulinum toxin type A and the cholinergic neuromuscular junction." The Journal of pharmacology and experimental therapeutics 212.1 (1980): 16-21.
description	3.	Poulain, B. "How botulinum and tetanus neurotoxins block neurotransmitter release." Biochimie 82.5 (2000): 427-46.
description	4.	Schiavo, G. "The journey of tetanus and botulinum neurotoxins in neurons." Trends in microbiology 11.9: 431-437.
description	5.	Zuniga, Jorge E. "Iterative structure-based peptide-like inhibitor design against the botulinum neurotoxin serotype A." PLoS ONE 5.6 (2010).
description	6.	Schiavo, G. "Neurotoxins affecting neuroexocytosis." Physiological reviews 80.2 (2000): 717-766.
description	7.	Breidenbach, Mark A A. "New insights into clostridial neurotoxin-SNARE interactions." Trends in molecular medicine 11.8 (2005): 377-81.
description	8.	Dolly, J O. "Acceptors for botulinum neurotoxin reside on motor nerve terminals and mediate its internalization." Nature 307.5950 (1984): 457-460.
description	9.	Montecucco, C. "Botulinum neurotoxins: mechanism of action and therapeutic applications." Molecular Medicine Today 2.10 (1996): 418-424.
description	10.	Kushmerick, C. "Physiological temperatures reduce the rate of vesicle pool depletion and short-term depression via an acceleration of vesicle recruitment." The journal of neuroscience 26.5 (2006): 1366-1377.
description	11.	Schiavo, G. "Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin." Nature 359.6398 (1992): 832-5.
description	12.	Breidenbach, A. "2.3 A crystal structure of tetanus neurotoxin light chain." Biochemistry 44.20 (2005): 7450-7457.
description	13.	Baldwin, M. "Association of botulinum neurotoxin serotypes A and B with synaptic vesicle protein complexes." Biochemistry 46.11 (2007): 3200-3210.
description	14.	Burnett, James C. "Conformational sampling of the botulinum neurotoxin serotype A light chain: implications for inhibitor binding." Bioorganic & medicinal chemistry 13.2 (2005): 333-41.
description	15.	Turton, K. "Botulinum and tetanus neurotoxins: structure, function and therapeutic utility." Trends in biochemical sciences 27.11 (2002): 552-558.
description	16.	Roeder, T. "Octopamine in invertebrates." Progress in Neurobiology 59.5 (1999): 533-561.
description	17.	Aoki, K Roger R. "Pharmacology and immunology of botulinum toxin type A." Clinics in dermatology 21.6: 476-480.
description	18.	Jahn, R. "SNAREs - engines for membrane fusion." Nature reviews. Molecular cell biology 7.9 (2006): 631-643.
description	19.	Swaminathan, S. "Molecular structures and functional relationships in clostridial neurotoxins." The FEBS journal 278.23 (2011): 4467-4485.
description	20.	Simpson, Lance L L. "Identification of the major steps in botulinum toxin action." Annual review of pharmacology and toxicology 44.2004 (2004): 167-93.